<DOC>
	<DOCNO>NCT01689194</DOCNO>
	<brief_summary>This clinical trial Phase II trial evaluate efficacy induction chemotherapy use Genexol-PM + cisplatin locally advanced head neck cancer . The investigator try evaluate response rate Genexol-PM + cisplatin chemotherapy , safety profile .</brief_summary>
	<brief_title>Efficacy Study Genexol-PM Cisplatin Locally Advanced Head Neck Cancer</brief_title>
	<detailed_description />
	<mesh_term>Carcinoma</mesh_term>
	<mesh_term>Carcinoma , Squamous Cell</mesh_term>
	<mesh_term>Head Neck Neoplasms</mesh_term>
	<mesh_term>Cisplatin</mesh_term>
	<criteria>locally advanced head neck squamous cell carcinoma oral cavity , oropharynx , hypopharynx , larynx measurable lesion unresectable age 18 ECOG 0 1 distant metastasis pregnancy prior chemotherapy radiation therapy 2ndary malignancy unfit medical condition</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>April 2016</verification_date>
</DOC>